Benitec Biopharma Inc. Share Price & Technical Analysis
BNTC · $10.40 (-1.70%)
Healthcare / Biotechnology
$10.40
-1.70%
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single ad…
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
-8% return in Jun, -12% avg return in past 3 year Jun month.
-20% return in 2026, 80% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -10% | -9% | -1% | 12% | -3% | -8% | – | – | – | – | – | – | -20% |
| 25 | -11% | 10% | 2% | 4% | 13% | -25% | -7% | 21% | 6% | 18% | -2% | 5% | 36% |
| 24 | -12% | 66% | 11% | 65% | -10% | -9% | 25% | 5% | 2% | 14% | -4% | 25% | 175% |
| 23 | 26% | 31% | -33% | -3% | 24% | -2% | -24% | 0% | 0% | 24% | -11% | -3% | 28% |
| 22 | -8% | -7% | 3% | -34% | -30% | 16% | -15% | -17% | -50% | -55% | 9% | -17% | -205% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$368.62M
P/E ratio
—
52W high
$17.15
52W low
$9.85
Volume
88,411
Beta
0.28
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Benitec Biopharma Inc. share price today?
- Benitec Biopharma Inc. (BNTC) last traded around $10.40 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BNTC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BNTC. Download the app for real-time alerts.
- How can I analyze Benitec Biopharma Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.